Login
Israel-Hamas Conflict
Memorial Day
Cannes Film Festival
Baseball
Social Media
World Cup
Premier League
Motorsports
Champions League
Sanctions
Disney
Wrestling
US Politics
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

A Look at the Phase II SAGA Data for Gildeuretinol in Geographic Atrophy

Summary by MedPage Today
(MedPage Today) -- An oral investigational agent, gildeuretinol (ALK-001), demonstrated a significant reduction in geographic atrophy (GA) lesion growth and improvements in low luminance visual function in the phase II SAGA trial, according to...

3 Articles

All
Left
Center
1
Right
MedPage TodayMedPage Today
Reposted by
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News
Center

A Look at the Phase II SAGA Data for Gildeuretinol in Geographic Atrophy

(MedPage Today) -- An oral investigational agent, gildeuretinol (ALK-001), demonstrated a significant reduction in geographic atrophy (GA) lesion growth and improvements in low luminance visual function in the phase II SAGA trial, according to...

·New York, United States
Read Full Article
modernretina.commodernretina.com

Early Intervention Helps with Vision Protection in Macular Degeneration

Retina specialist Priya Vakharia, MD, reveals promising ANX007 trial results, showing potential to prevent vision loss in geographic atrophy.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Anti-Aging, Acupuncture and Health News broke the news in on Thursday, May 22, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
SearchBlindspotLocal